Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1CNS 1

Conditions

Sinonasal undifferentiated carcinoma 1Melanoma 1Fistula 1Esthesioneuroblastoma, Olfactory 1Carcinoma, Squamous Cell 1Carcinoma, Mucoepidermoid 1Carcinoma, Adenoid Cystic 1

Interventions

Docetaxel 2tanespimycin 1sargramostim 1pentetreotide 1entinostat 1aldesleukin 1Vorinostat 1Thalidomide 1SUB1 protein, human 1Ritonavir 1Radiotherapy, Intensity-Modulated 1Radiotherapy 1Protons 1Nicotine 1Indinavir 1Gemcitabine 1Filgrastim 1Fentanyl 1Cyclophosphamide 1Cryosurgery 117-(dimethylaminoethylamino)-17-demethoxygeldanamycin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Esthesioneuroblastoma, Olfactory × Protons × Dermatologic × Clear all
NCT01586767 2023-09-21

Intensity-Modulated or Proton Radiation Therapy for Sinonasal Malignancy

Massachusetts General Hospital

Phase NA Unknown
45 enrolled
CNSDermatologic

Sinonasal undifferentiated carcinoma, Carcinoma, Squamous Cell, Carcinoma, Adenoid Cystic, Fistula, Melanoma, Carcinoma, Mucoepidermoid, Esthesioneuroblastoma, Olfactory

Data powered by HemOnc (CC BY 4.0) Colophon âš¡